Hormonal markers of aging in men with laryngeal carcinoma

Head and Neck

Volumn 27, Issue 3, 2005, Pages 243-247

  Jóźków, Paweł ^a   Mȩdraś, Marek ^a   Krȩcicki, Tomasz ^a   Zalesska Krȩcicka, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

DHEA S; Dihydrotestosterone; Estradiol; IGF 1; Laryngeal carcinoma; Male aging; SHBG; Testosterone

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; HORMONE; HORMONE BINDING PROTEIN; PRASTERONE SULFATE; SOMATOMEDIN C; TESTOSTERONE; TUMOR MARKER;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ESTRADIOL BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TESTOSTERONE BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; DIHYDROTESTOSTERONE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; TESTOSTERONE;

EID: 14644405633     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20143     Document Type: Article

References (28)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, Vol. VII. Lyon, France: IARC Scientific Publications No. 143. 1997. p 840-841.
2. Krȩcicki T, Zalesska-Krȩcicka M, Jagas M, Szajowski K, Rak J. Laryngeal cancer in Lower Silesia: descriptive analysis of 501 cases. Oral Oncol 1998;34:377-380.
3. Maier H, Tisch M. Epidemiology of laryngeal cancer: results of the Heidelberg case-control study. Acta Otolaryngol Suppl 1997;527:160-164.
4. Ferlito A. Neoplasms of the larynx. Edinburgh: Churchill Livingstone; 1993. p 1-618.
5. Kleinsasser O. Tumors of the larynx and hypopharynx. Stuttgart: Georg Thieme Verlag; 1988. p 2-16.
6. Ferrini RL, Barrett Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;147:750-754.
7. Leifke E, Gorenoi V, Wichers C, Von Zur Muhlen A, Von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000;53:689-695.
8. Jenkins JS. The voice of the castrato. Lancet 1998;351:1877-1880.
9. Mȩdraś M, Jóźków P, Krȩcicki T, Zalesska-Krȩcicka M. Analogies between laryngeal and prostate cancers - frequent malignancies of the elderly. Aging Male 2001;4:57-61.
10. Szmeja Z, Kruk-Zagajewska A, Kozak W, Szyfter W, Wójtowicz J. Hormony płciowe u chorych na raka krtani. Otolaryng Pol 1994;48:124-131.
11. Kleemann D. Testosterone versus dihydrotestosterone effects on permanent squamous epithelial cancer cell lines of the larynx. Laryngorhinootologie 1993;72:402-405.
12. Kambic V, Radsel Z, Prezelj J, Zargi M. Testosterone - an etiological factor in the development of laryngeal carcinoma? HNO 1985;33:115-117.
13. Wang JQ, Dong Z, Zhu JG, Bu GX, Guo XF. Androgen receptors in laryngeal carcinoma and their clinical significance. Chin Med J (Engl) 1991;104:992-994.
14. Wu AH, Whittemore AS, Kolonel LN, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 1995;4:735-741.
15. Dai WS, Gutai JP, Kuller LH, Cauley JA. Cigarette smoking and serum sex hormones in men. Am J Epidemiol 1988;128:796-805.
16. Goldberg P, Leclerc A, Luce D, Morcet JF, Brugere J. Laryngeal and hypopharyngeal cancer and occupation: results of a case-control study. Occup Environ Med 1997;54:477-482.
17. Sokic SI, Adanja BJ, Marinkovic JP, Vlajinac HD. Risk factors for laryngeal cancer. Eur J Epidemiol 1995;11:431-433.
18. Zatonski W, Becher H, Lissowska J, Wahrendorf J. Tobacco, alcohol and diet in the etiology of laryngeal cancer: a population-based case-control study. Cancer Causes Control 1991;2:3-10.
19. Bobin JY, Mayer M, Saez S. Role of androgens on larynx tumour growth. Cancer Treat Rep 1979;63:1195-1202.
20. Deitmer T, Knuth UA. Does sex hormone balance modify the pathogenesis of laryngeal cancer? Laryngol Rhinol Otol (Stuttg) 1986;65:392-394.
21. Kleemann D, Kunkel S. Serum dihydrotestosterone versus total testosterone values of patients with laryngeal carcinomas and chronic laryngitis. Laryngorhinootologie 1996;75:351-355.
22. Mȩdraś M, Jóźków P, Krȩcicki T, Zalesska-Krȩcicka M. Androgeny a rak krtani. Otolaryng Pol 2000;5:523-529.
23. Filippov KG, Andreev VG, Sergeeva TN, Tsypliakovskaia, LM. Tumor markers and hormonal homeostasis in laryngeal cancer. Med Radiol (Mosk) 1988;33:41-45.
24. Kushlinski NE, Bassalyk LS, Alferov VS, Ogoltsova ES, Savinskaia AP. Testosterone, albumin and sex steroid-binding globulin in the blood serum of patients with laryngeal cancer. Vopr Onkol 1985;31:36-41.
25. Haidoutova R, Melamed M, Dimitrova S, Kyossovska R. Investigations of serum testosterone levels in patients with laryngeal cancers. Arch Otorhinolaryngol 1985;241:213-217.
26. Khosravi J, Diamandi A, Mistry J, Scorilas A. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J Clin Endocrinol Metab 2001;86:694-699.
27. Stattin P, Bylund A, Rinaldi S, et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2000;92:1910-1917.
28. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, et al. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 1996;81:2534-2540.